Affinity capture elution bridging assay: A novel immunoassay format for detection of anti-therapeutic protein antibodies

The ACE-Bridge format provides an often superior option as a screening method to monitor patient ADA responses. This method is unique in its ability to measure ADA in the presence of high circulating endogenous target concentrations (> 100 ng/mL) while demonstrating very high drug tolerance.